Israele - ebraico - Ministry of Health

novartis israel ltd - sacubitril/valsartan as sodium salt complex - טבליות מצופות פילם - sacubitril/valsartan as sodium salt complex 24/26 mg - valsartan and sacubitril

Israele - ebraico - Ministry of Health

novartis israel ltd - sacubitril/valsartan as sodium salt complex - טבליות מצופות פילם - sacubitril/valsartan as sodium salt complex 24/26 mg - valsartan and sacubitril

Israele - ebraico - Ministry of Health

יוניליוור ישראל טיפוח אישי וביתי בעמ - שיפור מראה העור

Israele - ebraico - Ministry of Health

teva pharmaceutical industries ltd, israel - aloe; aloin; belladonna dry extract; ipecacuanha; phenolphthalein - טבליה - ipecacuanha 4 mg; belladonna dry extract 2.7 mg; aloin 4.5 mg; aloe 6 mg; phenolphthalein 32 mg - contact laxatives in combination - contact laxatives in combination - constipation.

Israele - ebraico - Ministry of Health

מדיגל בע"מ - כלל האוכלוסיה - אינהלציה ביתית

Israele - ebraico - Ministry of Health

bioavenir ltd, israel - piperacillin as sodium salt; tazobactam as sodium salt - אבקה להכנת תמיסה לזריקה - tazobactam as sodium salt 500 mg; piperacillin as sodium salt 4000 mg - tazobactam - tazobactam - antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms.tazo-pip avenir in combination with an aminoglycoside, is indicated for the treatment of suspected bacterial infections in neutropenic adults and children. appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

Israele - ebraico - Ministry of Health

bioavenir ltd - ampicillin as sodium salt; sulbactam as sodium salt - אבקה להכנת תמיסה לזריקה - ampicillin as sodium salt 1000 mg; sulbactam as sodium salt 500 mg - sulbactam

Israele - ebraico - Ministry of Health

bioavenir ltd, israel - ampicillin as sodium salt; sulbactam as sodium salt - אבקה להכנת תמיסה לזריקה - ampicillin as sodium salt 2000 mg; sulbactam as sodium salt 1000 mg - sulbactam

Israele - ebraico - Ministry of Health

novartis israel ltd - imatinib as mesylate - טבליות מצופות פילם - imatinib as mesylate 100 mg - imatinib - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). glivec is also indicated for the treament of : adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph + all as monotherapy. adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements. adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic l

Israele - ebraico - Ministry of Health

novartis israel ltd - imatinib as mesylate - טבליות מצופות פילם - imatinib as mesylate 400 mg - imatinib - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). glivec is also indicated for the treament of : adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph + all as monotherapy. adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements. adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic l